Evidence from a few studies indicates the existence of several issues related to psychiatric patients’ decisional capacity to give informed consent to clinical research. Clinicians often face difficulties in acquiring valid informed consent in clinical practice and even more so in drug trials. Participants often fail to fully understand or retain information regarding the actual implications of research protocols. The Brief Assessment for Consent to Clinical Research (BACO) was developed to investigate capacity to consent to clinical trials and further compare patients with schizophrenia and healthy comparisons’ decisional capacity. A method to avoid possible confounding effects of choosing a treatment regarding a current disease was applied. The study groups were administered the BACO and the MacArthur Competence Assessment Tool for Clinical Research. Psychiatric patients performed poorer in comprehending, appreciating, and reasoning abilities, than their healthy counterparts. Impaired cognitive functioning and psychiatric symptoms severity were associated with reduced capacity to consent.
Decisional capacity to consent to clinical research involving placebo in psychiatric patients / Parmigiani, Giovanna; Mandarelli, Gabriele; Dacquino, Claudia; Pompili, PIERITALO MARIA; LELLI-CHIESA, Giovanni; Ferracuti, Stefano. - In: JOURNAL OF FORENSIC SCIENCES. - ISSN 0022-1198. - 61:2(2016), pp. 388-393. [10.1111/1556-4029.13000]
Decisional capacity to consent to clinical research involving placebo in psychiatric patients
PARMIGIANI, GIOVANNA;
2016
Abstract
Evidence from a few studies indicates the existence of several issues related to psychiatric patients’ decisional capacity to give informed consent to clinical research. Clinicians often face difficulties in acquiring valid informed consent in clinical practice and even more so in drug trials. Participants often fail to fully understand or retain information regarding the actual implications of research protocols. The Brief Assessment for Consent to Clinical Research (BACO) was developed to investigate capacity to consent to clinical trials and further compare patients with schizophrenia and healthy comparisons’ decisional capacity. A method to avoid possible confounding effects of choosing a treatment regarding a current disease was applied. The study groups were administered the BACO and the MacArthur Competence Assessment Tool for Clinical Research. Psychiatric patients performed poorer in comprehending, appreciating, and reasoning abilities, than their healthy counterparts. Impaired cognitive functioning and psychiatric symptoms severity were associated with reduced capacity to consent.File | Dimensione | Formato | |
---|---|---|---|
Parmigiani_Decisional capacity to consent_2016.pdf
Accesso riservato
Dimensione
93.91 kB
Formato
Adobe PDF
|
93.91 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris